Song Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Song Li has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Cha Chen
The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China
2 shared publications Chao Yang
The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China
2 shared publicationsDexing Han
Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publicationsHaimin Luo
The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China
2 shared publicationsJiaqi Liang
Guangzhou Panyu District Health Management Center (Panyu District Rehabilitation Hospital), Guangzhou, China
2 shared publicationsJunhui Feng
Guangzhou Kingmylab Pharmaceutical Research Co., Ltd., Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 11 February 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1675468
The small non-coding RNA sRNA102 regulates Pseudomonas aeruginosa virulence and host immunity by targeting the T3SS component PcrG
This study investigates the regulatory role of a functionally under-characterized small non-coding RNA (sRNA), sRNA102, in Pseudomonas aeruginosa , focusing on its mechanisms of influencing bacterial virulence and host immune modulation. Using an in vivo murine intraperitoneal infection model and transcriptomic sequencing, we found that the expression of sRNA102 is host immune-dependent: its expression was significantly upregulated by approximately 3-fold in immunocompetent mouse infection models, whereas no significant upregulation was observed in immunodeficient mouse models. This trend was further validated in in vitro PAO1-immune cell co-culture systems and a whole-blood infection model. Functional studies demonstrated that sRNA102 enhances hemolytic activity by 2.5-fold, reduces cytotoxicity toward A549 epithelial cells by approximately 43%, and increases adhesion and invasion capabilities by 2.1-fold. Mechanistically, we confirmed that sRNA102 directly targets and positively regulates pcrG, a key gene of the type III secretion system (T3SS), thereby upregulating the expression of the downstream effector protein ExoS. In infection models, the expression of sRNA102 suppressed the expression of the anti-inflammatory cytokine interleukin-10 (IL-10) (downregulated by approximately 50% in the sRNA102-overexpressing infection group), while promoting the expression of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-α) and the immunomodulatory marker arginase 1 (Arg1), ultimately leading to increased bacterial colonization in the mouse peritoneal cavity. These findings reveal a novel regulatory pathway driven by sRNA102, which integrates the pcrG-exoS-T3SS axis to modulate bacterial virulence and host immune responses, deepening our understanding of the fine-tuned, sRNA-mediated regulatory mechanisms during P. aeruginosa infection.
- 11 February 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1675468
Open AccessThe small non-coding RNA sRNA102 regulates Pseudomonas aeruginosa virulence and host immunity by targeting the T3SS component PcrG
This study investigates the regulatory role of a functionally under-characterized small non-coding RNA (sRNA), sRNA102, in Pseudomonas aeruginosa , focusing on its mechanisms of influencing bacterial virulence and host immune modulation. Using an in vivo murine intraperitoneal infection model and transcriptomic sequencing, we found that the expression of sRNA102 is host immune-dependent: its expression was significantly upregulated by approximately 3-fold in immunocompetent mouse infection models, whereas no significant upregulation was observed in immunodeficient mouse models. This trend was further validated in in vitro PAO1-immune cell co-culture systems and a whole-blood infection model. Functional studies demonstrated that sRNA102 enhances hemolytic activity by 2.5-fold, reduces cytotoxicity toward A549 epithelial cells by approximately 43%, and increases adhesion and invasion capabilities by 2.1-fold. Mechanistically, we confirmed that sRNA102 directly targets and positively regulates pcrG, a key gene of the type III secretion system (T3SS), thereby upregulating the expression of the downstream effector protein ExoS. In infection models, the expression of sRNA102 suppressed the expression of the anti-inflammatory cytokine interleukin-10 (IL-10) (downregulated by approximately 50% in the sRNA102-overexpressing infection group), while promoting the expression of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-α) and the immunomodulatory marker arginase 1 (Arg1), ultimately leading to increased bacterial colonization in the mouse peritoneal cavity. These findings reveal a novel regulatory pathway driven by sRNA102, which integrates the pcrG-exoS-T3SS axis to modulate bacterial virulence and host immune responses, deepening our understanding of the fine-tuned, sRNA-mediated regulatory mechanisms during P. aeruginosa infection.
- Open Access
- 17 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1
Author Correction: Genomic epidemiology and phenotypic characterization of Staphylococcus aureus isolated from atopic dermatitis patients in South China
- 17 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1
Open AccessAuthor Correction: Genomic epidemiology and phenotypic characterization of Staphylococcus aureus isolated from atopic dermatitis patients in South China
- 15 March 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 757, 151643
Study of the antimicrobial activity of carvacrol and its mechanism of action against drug-resistant bacteria
- 15 March 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 757, 151643
Study of the antimicrobial activity of carvacrol and its mechanism of action against drug-resistant bacteria
- Open Access
- 8 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Genomic epidemiology and phenotypic characterization of Staphylococcus aureus isolated from atopic dermatitis patients in South China
Atopic dermatitis (AD) is a multifactorial, chronic relapsing disease. Staphylococcus aureus is the key microbial factor in AD, linked to disease activity. However, there is limited knowledge of genomic prevalence characteristics and phenotypic features of S. aureus in AD patients in China. We investigated 108 S. aureus of AD in China and globally publicly available genome sequences of 579 S. aureus of AD. Sequence type (ST) 7, ST15 and ST188 were the major lineages in China. Genes esaC, esxB, and sea were only detected in ST7, potentially contributing to its prevalence in AD. ST188 exhibited high virulence and adhesion, possibly due to the cna gene. Phylogenetic and population structure analysis revealed that 579 strains of global AD were classified into 15 sequence clusters (SCs), with SC5, SC2, and SC7 dominating. S. aureus of Chinese AD patients was mainly distributed in SC2, SC7, and SC12. Comparative genomic highlighted genes linked to AD, including enterotoxins (seh, selk, selq, entH), adhesion genes (fnbA, fnbB, sdrD, map, fib, narH). From China and global perspectives, we analyzed S. aureus’s genomic epidemic traits, phylogeny, and population structure in AD skin. These findings contribute to understanding S. aureus-host interactions and genomic diversity in AD.
- 8 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessGenomic epidemiology and phenotypic characterization of Staphylococcus aureus isolated from atopic dermatitis patients in South China
Atopic dermatitis (AD) is a multifactorial, chronic relapsing disease. Staphylococcus aureus is the key microbial factor in AD, linked to disease activity. However, there is limited knowledge of genomic prevalence characteristics and phenotypic features of S. aureus in AD patients in China. We investigated 108 S. aureus of AD in China and globally publicly available genome sequences of 579 S. aureus of AD. Sequence type (ST) 7, ST15 and ST188 were the major lineages in China. Genes esaC, esxB, and sea were only detected in ST7, potentially contributing to its prevalence in AD. ST188 exhibited high virulence and adhesion, possibly due to the cna gene. Phylogenetic and population structure analysis revealed that 579 strains of global AD were classified into 15 sequence clusters (SCs), with SC5, SC2, and SC7 dominating. S. aureus of Chinese AD patients was mainly distributed in SC2, SC7, and SC12. Comparative genomic highlighted genes linked to AD, including enterotoxins (seh, selk, selq, entH), adhesion genes (fnbA, fnbB, sdrD, map, fib, narH). From China and global perspectives, we analyzed S. aureus’s genomic epidemic traits, phylogeny, and population structure in AD skin. These findings contribute to understanding S. aureus-host interactions and genomic diversity in AD.